DE3061688D1 - 4-(substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione compounds, processes for preparing and a pharmaceutical composition comprising the same - Google Patents
4-(substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione compounds, processes for preparing and a pharmaceutical composition comprising the sameInfo
- Publication number
- DE3061688D1 DE3061688D1 DE8080105409T DE3061688T DE3061688D1 DE 3061688 D1 DE3061688 D1 DE 3061688D1 DE 8080105409 T DE8080105409 T DE 8080105409T DE 3061688 T DE3061688 T DE 3061688T DE 3061688 D1 DE3061688 D1 DE 3061688D1
- Authority
- DE
- Germany
- Prior art keywords
- pyrroline
- hydroxy
- preparing
- processes
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/074,465 US4298743A (en) | 1979-09-11 | 1979-09-11 | 4-(Substituted phenyl thiazolyl)-3-hydroxy-3-pyrroline-2,5-diones |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3061688D1 true DE3061688D1 (en) | 1983-02-24 |
Family
ID=22119703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8080105409T Expired DE3061688D1 (en) | 1979-09-11 | 1980-09-10 | 4-(substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione compounds, processes for preparing and a pharmaceutical composition comprising the same |
Country Status (9)
Country | Link |
---|---|
US (1) | US4298743A (de) |
EP (1) | EP0025232B1 (de) |
JP (1) | JPS5646809A (de) |
AT (1) | ATE2271T1 (de) |
DE (1) | DE3061688D1 (de) |
DK (1) | DK384280A (de) |
ES (1) | ES8105996A1 (de) |
GR (1) | GR70200B (de) |
PT (1) | PT71755B (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4379791A (en) * | 1979-09-11 | 1983-04-12 | Merck & Co., Inc. | 4-(Substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase |
US4700901A (en) * | 1985-08-19 | 1987-10-20 | Breville R & D Pty. Limited | Food processors |
DK0934937T3 (da) * | 1990-11-30 | 2002-04-02 | Otsuka Pharma Co Ltd | Azolderivater som superoxidradikalinhibitor |
MY128323A (en) * | 1996-09-30 | 2007-01-31 | Otsuka Pharma Co Ltd | Thiazole derivatives for inhibition of cytokine production and of cell adhesion |
US6313156B1 (en) | 1999-12-23 | 2001-11-06 | Icos Corporation | Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors |
DE10029077A1 (de) | 2000-06-13 | 2001-12-20 | Bayer Ag | Thiazolylsubstituierte Heterocyclen |
ATE550320T1 (de) * | 2001-08-10 | 2012-04-15 | Shionogi & Co | Antivirales mittel |
US6858615B2 (en) | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenyl guanidine sodium channel blockers |
US6858614B2 (en) * | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenolic guanidine sodium channel blockers |
US7144911B2 (en) | 2002-12-31 | 2006-12-05 | Deciphera Pharmaceuticals Llc | Anti-inflammatory medicaments |
US7202257B2 (en) | 2003-12-24 | 2007-04-10 | Deciphera Pharmaceuticals, Llc | Anti-inflammatory medicaments |
US7279576B2 (en) | 2002-12-31 | 2007-10-09 | Deciphera Pharmaceuticals, Llc | Anti-cancer medicaments |
US6903105B2 (en) | 2003-02-19 | 2005-06-07 | Parion Sciences, Inc. | Sodium channel blockers |
US7745442B2 (en) | 2003-08-20 | 2010-06-29 | Parion Sciences, Inc. | Methods of reducing risk of infection from pathogens |
AU2005321946B2 (en) | 2004-12-23 | 2012-08-16 | Deciphera Pharmaceuticals, Llc | Enzyme modulators and treatments |
US8188113B2 (en) | 2006-09-14 | 2012-05-29 | Deciphera Pharmaceuticals, Inc. | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
US7790756B2 (en) | 2006-10-11 | 2010-09-07 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
WO2008131253A1 (en) | 2007-04-20 | 2008-10-30 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
MX2011004535A (es) | 2008-10-29 | 2011-11-18 | Deciphera Pharmaceuticals Llc | Ciclopropanamidas y analogos que exhiben actividades anti-cancer y anti-proliferativas. |
AR086745A1 (es) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida |
US8461179B1 (en) | 2012-06-07 | 2013-06-11 | Deciphera Pharmaceuticals, Llc | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
CA2895512C (en) | 2012-12-17 | 2021-10-19 | Parion Sciences, Inc. | Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration |
MX2015007797A (es) | 2012-12-17 | 2015-10-05 | Parion Sciences Inc | Compuestos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil) carbamimidoil) pirazin-2-carboxamida. |
US9102633B2 (en) | 2013-12-13 | 2015-08-11 | Parion Sciences, Inc. | Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds |
SG11202007198WA (en) | 2018-01-31 | 2020-08-28 | Deciphera Pharmaceuticals Llc | Combination therapy for the treatment of gastrointestinal stromal tumors |
BR112022002609A2 (pt) | 2019-08-12 | 2022-08-09 | Deciphera Pharmaceuticals Llc | Métodos de tratamento de tumores estromais gastrointestinais |
WO2021030405A1 (en) | 2019-08-12 | 2021-02-18 | Deciphera Pharmaceuticals, Llc | Ripretinib for treating gastrointestinal stromal tumors |
DK4084778T3 (da) | 2019-12-30 | 2023-12-11 | Deciphera Pharmaceuticals Llc | Amorfe kinaseinhibitorformuleringer og fremgangsmåder til anvendelse deraf |
KR20220123058A (ko) | 2019-12-30 | 2022-09-05 | 데시페라 파마슈티칼스, 엘엘씨. | 1-(4-브로모-5-(1-에틸-7-(메틸아미노)-2-옥소-1,2-디히드로-1,6-나프티리딘-3-일)-2-플루오로페닐)-3-페닐우레아의 조성물 |
US11779572B1 (en) | 2022-09-02 | 2023-10-10 | Deciphera Pharmaceuticals, Llc | Methods of treating gastrointestinal stromal tumors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE599556A (de) * | 1960-02-01 | |||
US3340263A (en) * | 1964-02-14 | 1967-09-05 | Ciba Geigy Corp | Amino-pyrroles |
GB1127875A (en) * | 1967-03-23 | 1968-09-18 | Parke Davis & Co | 4-(5-nitro-2-furyl) thiazolyl hydantoins and hydrouracils |
GB1304174A (de) * | 1969-03-07 | 1973-01-24 |
-
1979
- 1979-09-11 US US06/074,465 patent/US4298743A/en not_active Expired - Lifetime
-
1980
- 1980-08-29 PT PT71755A patent/PT71755B/pt unknown
- 1980-09-08 GR GR62835A patent/GR70200B/el unknown
- 1980-09-10 DK DK384280A patent/DK384280A/da not_active Application Discontinuation
- 1980-09-10 ES ES494933A patent/ES8105996A1/es not_active Expired
- 1980-09-10 EP EP80105409A patent/EP0025232B1/de not_active Expired
- 1980-09-10 AT AT80105409T patent/ATE2271T1/de not_active IP Right Cessation
- 1980-09-10 DE DE8080105409T patent/DE3061688D1/de not_active Expired
- 1980-09-11 JP JP12536980A patent/JPS5646809A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PT71755B (en) | 1982-03-19 |
JPS5646809A (en) | 1981-04-28 |
EP0025232B1 (de) | 1983-01-19 |
EP0025232A1 (de) | 1981-03-18 |
ATE2271T1 (de) | 1983-02-15 |
GR70200B (de) | 1982-08-31 |
ES494933A0 (es) | 1981-07-01 |
ES8105996A1 (es) | 1981-07-01 |
US4298743A (en) | 1981-11-03 |
PT71755A (en) | 1980-09-01 |
DK384280A (da) | 1981-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3061688D1 (en) | 4-(substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione compounds, processes for preparing and a pharmaceutical composition comprising the same | |
DE3060801D1 (en) | 4-substituted-3-hydroxy-3-pyrroline-2,5-dione compounds, process for their preparation and pharmaceutical compositions containing the same | |
NL950007I1 (nl) | 1,2,4-Triazinederivaten, werkwijze voor de bereid ing van deze verbindingen, en deze verbindingen bevattende farmaceutische preparaten. | |
HK121293A (en) | Desulfatohirudine,process for its preparation and pharmaceutical agent | |
DE3270015D1 (en) | 3-(1-substituted-4-piperidyl)-1,2-benzisoxazoles, a process for the preparation thereof, a pharmaceutical composition comprising the same, and their use as medicaments | |
IT8019049A0 (it) | Composti 2 penem, metodo per laloro preparazione e composizioni farmaceutiche contenenti tali composti. | |
EP0328251A3 (en) | 2-(2-hydroxy-3-phenoxypropylamino)ethylphenoxyacetamides and processes and intermediates for their preparation | |
EP0293751A3 (en) | Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia | |
ZA941021B (en) | Condensed 5-membered heterocyclic compounds, processes for preparing them and pharmaceutical compositions containing these compounds. | |
ZA886097B (en) | Pharmaceutical composition for the treatment of psoriasis | |
ES8205201A1 (es) | Un procedimiento para la preparacion de 4-alquil-sustituido-3--hidroxi-3-pirrolin-2,5 dionas. | |
IL61989A (en) | 1-(1,3,4-oxadiazolyl-phenoxy)-3-(phenylpiperazino)propan-2-ols and their derivatives,their preparation and pharmaceutical compositions containing them | |
ZA806786B (en) | 4-substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase | |
NO913683L (no) | Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer. | |
SG153894G (en) | Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient | |
FI930269A (fi) | Komposition som aostadkommer ett foerbaettrat undanroejande av bioaktiva substanser fraon blodfloedet | |
PT72802B (en) | Process for preparing alpha-methyldopa compositions | |
AT389106B (de) | Neue styrylpyrazole, isoxazole und analoge davon, welche als 5-lipoxygenaseinhibitoren wirksam sind,sowie diese verbindungen enthaltende pharmazeutische zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |